Prescription Pattern Of Antidiabetic Medications In Type II Diabetes Mellitus Patients With Acute Myocardial Infraction: A Retrospective Observational Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- Annual Rate of number of prescriptions of type of anti-diabetic medications in T2DM with Acute MI.
研究概览
简要总结
Type II Diabetes Mellitus (T2DM) is a prevalent condition with reduced quality of life and increased mortality rates. Insulin resistance and relative insulin insufficiency are the main factors defining T2DM. Over 462 million people worldwide live with T2DM and it is a global growing disease burden. Even though metformin is consistently advised as the first-line medication for the treatment of T2DM, clinical guidelines have advised since January 2017 that the presence comorbidities specifically, cardiovascular disease, heart failure (HF), in addition to hypoglycemia should be taken into consideration when choosing a second-line therapy. The purpose of this study is to investigate trends in the annual prescription rate of anti-diabetic medications in patients with ASCVD and HF during the period 2019-2023.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •T2DM patients of either gender aged 18 years and above with at least one cardiovascular coexisting condition.
排除标准
- •Patient with type 1 diabetes mellitus
- •Keto acidosis
- •Pregnant women.
- •Patients with CKD as comorbid condition
- •Patient with stroke psychiatric disorders, neurological disorders, nephrology, hepatology, oncological, respiratory disorders, infectious disorders.
结局指标
主要结局
Annual Rate of number of prescriptions of type of anti-diabetic medications in T2DM with Acute MI.
时间窗: At admission and discharge
次要结局
- Demographic factors(Other antidiabetic drug)
研究者
Smera K P
NGSM Institute of Pharmaceutical Sciences